Is Bristol Myers Squibb a Good Dividend Stock to Buy Now?

A lowered outlook for 2024 and upcoming patent expirations have investors concerned about this pharmaceutical giant's dividend program.If you're looking for a way to permanently boost your passive income stream, you've probably seen Bristol Myers Squibb (BMY -2.91%) when you screen for stocks that pay big dividends.At recent prices, the Big Pharma stock offers a 4.7% yield. Unfortunately, dividend payers rarely offer such high yields unless there are reasons to suspect they can't maintain their payout-raisi ...